SCHEMBL21261092

SCHEMBL21261092

COc1ccc(C(=O)Nc2sc3c(c2C(=O)O)CCC(C)(C)C3)cc1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GLO1 Q04760 1/20 0.72
▸ MAPT P10636 7/20 0.68
▸ ALDH1A1 P00352 4/20 0.68
▸ SMN1; SMN2 Q16637 3/20 0.68
▸ LMNA P02545 2/20 0.68
▸ HPGD P15428 2/20 0.68
▸ FLT3 P36888 1/20 0.59
▸ RAB7A P51149 2/20 0.56
▸ MEN1 O00255 8/20 0.56
▸ KMT2A Q03164 8/20 0.56
▸ NOD1 Q9Y239 4/20 0.56
▸ SLC34A2 O95436 1/20 0.55
▸ TNF P01375 2/20 0.53
▸ GRIN2C Q14957 2/20 0.53
▸ KDM4E B2RXH2 2/20 0.53
▸ MITF O75030 1/20 0.53
▸ KLF5 Q13887 1/20 0.53
▸ NOD2 Q9HC29 1/20 0.52
▸ RAB9A P51151 4/20 0.52
▸ POLB P06746 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21247408 0.89 GLO1 (0.57) GLO1MAPTALDH1A1SMN1; SMN2LMNA
SCHEMBL22680862 0.88 MEN1 (0.69) GLO1MAPTALDH1A1SMN1; SMN2LMNA
SCHEMBL21260924 0.88 MEN1 (0.74) GLO1MAPTALDH1A1SMN1; SMN2LMNA
SCHEMBL21247395 0.88 GLO1 (0.56) GLO1MAPTALDH1A1SMN1; SMN2LMNA
SCHEMBL21247392 0.88 RAB7A (0.68) MAPTALDH1A1SMN1; SMN2LMNAHPGD
SCHEMBL21247339 0.87 MEN1 (0.69) GLO1MAPTALDH1A1SMN1; SMN2LMNA
SCHEMBL21247268 0.86 NOD1 (0.69) GLO1MAPTALDH1A1SMN1; SMN2LMNA
SCHEMBL21247290 0.85 GLO1 (0.53) GLO1MAPTALDH1A1SMN1; SMN2LMNA
SCHEMBL23413350 0.84 GLO1 (1.00) GLO1MAPTALDH1A1SMN1; SMN2LMNA
SCHEMBL21247185 0.84 GLO1 (0.52) GLO1MAPTALDH1A1SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11492347-B2 Fused thiophene derivatives and their uses ENYO PHARMA (FR) 2022-11-08 — — US disclosed
US-20200361924-A1 FUSED THIOPHENE DERIVATIVES AND THEIR USES ENYO PHARMA (FR) 2020-11-19 — — US disclosed
WO-2019154950-A1 FUSED THIOPHENE DERIVATIVES AND THEIR USES ENYO PHARMA (FR) 2019-08-15 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200361924-A1 FUSED THIOPHENE DERIVATIVES AND THEIR USES FTH1, SLC40A1, FECH GLO1 616/4885MAPT 2107/4885ALDH1A1 2143/4885
US-11492347-B2 Fused thiophene derivatives and their uses FTH1, SLC40A1, FECH GLO1 616/4885MAPT 2107/4885ALDH1A1 2143/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback